Research Studies and Publications

A National study evaluating patient and family financial burden associated with cancer treatment in Canada

Jan 15, 2020, 16:50 PM
Brief Summary :
Lead Investigator Name : Christopher Longo
Start Date :
End Date :
Christopher Longo leads a national study of the financial burden that cancer treatment puts on Canadian patients and families. 
The impact of a cancer diagnosis goes beyond the clinical and emotional complexities to include impacts on patient and family financial security, with those in low income populations or who lack private health insurance more severely affected. 

Christopher Longo leads a national study that evaluated the financial burden experienced by 901 patients from BC (131) Alberta (113), Manitoba (134), Ontario (472), and “rest of Canada” (51), including 344 breast, 183 colorectal, 158 lung and 216 prostate patients, with an average treatment duration of 318 days.

The research found that the financial cost of a cancer diagnosis nationally averages $2723 per month.  These results suggest an increase in Ontario of more than 200% in financial costs of a cancer diagnosis since 2003. Moreover, financial decisions to forego care appear to be high for a largely publicly funded healthcare system. 

Categories :
  • Centre for Health Economics and Policy Analysis
Tags :
  • Centre for Health Economics and Policy Analysis
Related contact bios
Related contact bios : Longo, Christopher
Related news

Accessibility for Ontarians With Disabilities Act (AODA)


The Faculty of Health Sciences is committed to providing a website that is accessible to the widest possible audience. If there is an accessibility issue with this website, please contact us at